Artiva Biotherapeutics, Inc. · NASDAQ:ARTV

GC Corp bought 1,432,291 Artiva Biotherapeutics, Inc. shares (Form 4)

Traded May 11, 2026 · Filed May 28, 2026

On May 11, 2026, GC Corp (10% owner) bought 1,432,291 Artiva Biotherapeutics, Inc. shares at US$11.52 for US$16.5M, leaving 1,607,734 shares. Filed May 28, 2026 (Form 4).

Bought
1,432,291 shares
Price
US$11.52
Value
US$16.5M
Holding after
1,607,734 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 11, 2026Common StockBuy1,085,069US$11.524,391,969Direct
May 11, 2026Common StockBuy347,222US$11.521,607,734Indirect

Source

View original at SEC

Related